HIGHBRIDGE CAPITAL MANAGEMENT LLC - INTERCEPT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 4 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$159,000
-15.0%
11,5000.0%0.00%0.0%
Q1 2022$187,000
-79.5%
11,500
-79.5%
0.00%
-80.0%
Q4 2021$912,000
-35.3%
56,000
-41.0%
0.02%
-45.9%
Q3 2021$1,409,000–94,900–0.04%–
 Download
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 11,500$187,0000.00%
SIMPLEX TRADING, LLC 142,300$2,315,0000.00%
GROUP ONE TRADING, L.P. 136,300$2,218,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders